Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose Morphine for Dyspnea in Advanced COPD
NCT00982891Phase 3Completed
- Sponsor
- Nova Scotia Health
- Start
- Mar 2010
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of morphine in chronic obstructive pulmonary disease (COPD), sponsored by Nova Scotia Health. Started Mar 2010; status: completed.
02
Drugs
morphine
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00982891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00982891.